A Phase 3 Trial of JKN2401 Injection in COPD

NCT07330310 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

888

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Interventions

BIOLOGICAL: JKN2401 Injection
OTHER: Placebo

Sponsor

Joincare Pharmaceutical Group Industry Co., Ltd